Julie M. Vose, MD, MBA
Division Chief
George and Peggy Payne Distinguished Chair of Oncology
Division of Hematology & Oncology
Non-Hodgkin Lymphoma, Hodgkin Disease, Multiple Myeloma, Chronic Lymphocytic Leukemia
Dr. Vose is an oncology and hematology physician and the Chief of the Division of Oncology and Hematology at the University of Nebraska Medical Center/Nebraska Medicine. Her personal research involves treating patients with non-Hodgkin lymphoma, Hodgkin lymphoma, and chronic lymphocytic leukemia. Her clinical areas of focus include chemotherapy, immunotherapy, cellular therapy, and pathway directed agents for treatment and clinical trial research.
Dr. Vose has been involved in oncology and hematology for more than 30 years and she had the honor of serving as the President of the American Society of Clinical Oncology (ASCO) in 2016. She has published more than 400 manuscripts on the treatment of patients with lymphoma or related entities.
Information
- Medical School: UNMC College of Medicine, 1984
- Residency: Internal Medicine, UNMC College of Medicine, 1987
- Residency: Internal Medicine, UNMC College of Medicine, 1988
- Fellowship: Hematology/Oncology, UNMC College of Medicine, 1990
- MBA: University of Colorado, 2011
Hospital Appointments: Nebraska Medicine
Clinic Locations: Fred & Pamela Buffett Cancer Center; Cancer Center at Village Pointe Health Center
Dr. Vose's research interests include:
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Stem Cell Transplantation
- CAR-T Cell Transplantation
Department of Internal Medicine
College of Medicine
University of Nebraska Medical Center
986840 Nebraska Medical Center
Omaha, NE 68198-6840